Search company, investor...

Accumed Systems

Founded Year



Series A | Alive

Total Raised


Last Raised

$1.29M | 22 yrs ago

About Accumed Systems

Accumed Systems is a Healthcare/Medical Devices & Equipment company based in Ann Arbor, Michigan. Accumed Systems has received investment from Michigan Life Sciences Corridor.

Headquarters Location

6109 Jackson Road

Ann Arbor, Michigan, 48103,

United States


Missing: Accumed Systems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Accumed Systems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Accumed Systems Patents

Accumed Systems has filed 11 patents.

The 3 most popular patent topics include:

  • Cardiac procedures
  • Blood
  • Blood tests
patents chart

Application Date

Grant Date


Related Topics




Units of length, Medical equipment, Catheters, Polymers, Metrology


Application Date


Grant Date



Related Topics

Units of length, Medical equipment, Catheters, Polymers, Metrology



Latest Accumed Systems News

Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer

May 21, 2013

ANN ARBOR, MI--(Marketwired - May 21, 2013) - Michael Pisano, PhD, has been appointed as President and CEO of Accumed Radial Systems, LLC (ARS), the newly formed wholly owned subsidiary of Accumed Systems, Inc. Dr. Pisano has been hired to provide ARS with direction and leadership toward the achievement of the company's mission and strategic goals and objectives. ARS (Ann Arbor, Michigan) is focused on providing tools for transradial catheterization procedures. ARS was recently created following successful development and commercialization of several transradial procedure accessories by the parent, and in response to increasing clinical demand for innovative products for use in performing transradial arterial procedures. The rapid uptake of the radial technique has created a unique opportunity for ARS' creative product development effort solely focused on the radial approach. With its core competencies ARS is positioned for rapid identification, development and marketing of innovative radial products. Dr. Pisano has more than twenty years' experience in the life sciences industry. He has held senior management positions in Pharmaceutical, Instrumentation and Medical Device companies as well as a Contract Research Organization. He started several companies and was President and CEO of NextGen Group, PLC a publicly traded company. According to William O'Neill, MD, Board Chair, "The time has arrived for Accumed Systems to launch ARS as an independent company. Dr. Pisano's background and experience will provide us with the expertise to harvest the needs of Key Opinion Leaders in the field and rapidly translate these needs to commercially viable products. " ARS' vision is to be the leading innovator in TRA products, bringing creativity, innovation and speed of development to bear. Its mission is to improve the ability of clinical operators to successfully adopt, perform and expand the use of radial access for any cardiovascular procedure by providing innovative technologies specific to the task. ARS's goals are to return shareholder value by leveraging its core competencies in identifying, developing and demonstrating clinical utility of such products. Ultimately these goals will be achieved by entering into partnerships with cardiovascular companies seeking to expand, secure or establish a position in the radial market. Contact Information

Accumed Systems Frequently Asked Questions (FAQ)

  • When was Accumed Systems founded?

    Accumed Systems was founded in 1990.

  • Where is Accumed Systems's headquarters?

    Accumed Systems's headquarters is located at 6109 Jackson Road, Ann Arbor.

  • What is Accumed Systems's latest funding round?

    Accumed Systems's latest funding round is Series A.

  • How much did Accumed Systems raise?

    Accumed Systems raised a total of $1.29M.

  • Who are the investors of Accumed Systems?

    Investors of Accumed Systems include Michigan Life Sciences Corridor and University of Texas System.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.